Skip to main content

Body odor metabolism map (V20)

Today we release a new curated metabolism map regarding body odor diseases.

The new map alignes around the main inhibited enzymes by body odor diseases.

Beside of that a first receptor linkage has been included.

The map further shows now measured chemical compounds in unnormal ranges of tmau2 and bromhidrosis with elevated TSH.

Obviously in the tmau2 case the measurements align pretty good with the assumption that the intestinal tract metabolism runs out of SAM (S-adenosyl-methionine) by defects in the homocysteine to methionine conversion.

https://drive.google.com/file/d/0B9gtX6As3TJGTDVfNDRfek1WLTA/view?usp=drivesdk

Comments

Popular posts from this blog

Glutamine and Glutamate seems to increase butyrate production in the large intestinal tract

Glutamine and its counterpart glutamate seems to increase the butyrate production in the intestinal tract. Butyrates show a biting or pungeant, light sweat like smell. This strengthens the view that the tight junction sealing is dominated by metabolite pathways that present in one or the other way highly smelling chemical compounds the body is forced to absorb to counter regulate its deregulated energy metabolism in the intestinal tract .

Bromhidrosis TSH+: Diet protocol + nystatin, nigella sativa + h1 receptor antagonists + medicinal clay improves body odor condition

In our explorative case we were further able to improve the diet protocol as well as finding a new drug/supplement  composition. We are taking advantage of following over the counter drugs/supplements: - Nystatin - Nigella sativa (black cumin) capsules - H1 receptor antagonists (loratadin) - medicinal clay The diet protocol was taken from: https://drive.google.com/folderview?id=19hmatFJPil1svc9DRyuRn3S9rUF7yqH_ Dosages (daily) applied were like the following: nystatin: 6x pills (3x at morning, 3x at evening) nigella sativa: >10000mg (5x 400mg capsules before every meal, 5 meals per day) loratadin: 50mg - 100mg daily medicinal clay: 6x 6g (luvos healing earth)

Candida pathogenesis in Bromhidrosis

Our observation was that bromhidrosis patients reported slight elevated candida sp. levels in combination mit reduced enterococcus sp. in stool analysis results. The current metabolism impact for bromhidrosis seems to be sourced in a deficient acetate or propionate degrading enzyme which is part of the major ethanol degradation. The biosynthesis of ethanol is mostly based on candida sp., so we investigated into the pathogenesis of candida. The following pictures show the resulting disease model. In the case of an deficiency in the ethanol degradation pathway, the immune system shows a weakness regarding the candida sp., which shifts the microbiome towards increased candida occurence and activity. This would lead to small intestinal fungal overgrowth (SIFO) symptoms